Efficacy assessment of salicylidene salicylhydrazide in chemotherapy associated peripheral neuropathy
- 1 December 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 888, 173481
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB2 Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral NeuropathyMolecular Pain, 2012
- Involvement of Substance P in Peripheral Neuropathy Induced by Paclitaxel but Not OxaliplatinThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Antinociceptive Effect of Memantine and Morphine on Vincristine-induced Peripheral Neuropathy in RatsThe Korean Journal of Pain, 2010
- Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment studyPain, 2009
- Mice with Cisplatin and Oxaliplatin-Induced Painful Neuropathy Develop Distinct Early Responses to Thermal StimuliMolecular Pain, 2009
- Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathyPain, 2004
- Salicylidene salicylhydrazide, a selective inhibitor ofβ1‐containing GABAAreceptorsBritish Journal of Pharmacology, 2004
- Slowly conducting afferents activated by innocuous low temperature in human skinThe Journal of Physiology, 2001
- Tail immersion test for the evaluation of a nociceptive reaction in miceJournal of Pharmacological Methods, 1989
- Noxious thermal input from the rat tail: Modulation by descending inhibitory influencesPain, 1977